Trial description:
A multicentre randomised phase III trial comparing atezolizumab plus bevacizumab and standard chemotherapy versus bevacizumab and standard chemotherapy as first-line treatment for advanced malignant pleural mesothelioma
Contact name:
Dr David Gilligan
Trial start date:
Thursday, September 5, 2019
Trial end date:
Wednesday, January 15, 2025
Trial tumour type:
Lung
Show on Radiotherapy:
No
